3de Miguel A, Ibanez B, Badimon J J. Clinical implications of clopidogrel resistance [ J ]. Thromb Haemost ,2005,100 : 196.
4Jefrey S B, Deepak L B, Christopher P C, et al. The relative efficacy and safety of clopidogrel in women andmen--A sex specific collaborative meta-analysis [ J ]. J Am ColI Cardio1,2009,54 : 1935.
5Adriane F B. Herb-drug interactions [ J ]. Lancet,2000, 355 : 134.
6Ara T J, Viqar M, Arshad J. Use of herbal products and potential interactions in patients with cardiovascular diseases[J~. J Am Coil Cardiol, 2010,55:515.
7He J, Gu D, Wu X, et al. Major causes of death among men and women in China[J]. N Engl J Med, 2005,353 (11) :1124.
8Mehta S R, Tanguay J F, Eikelboom J W, et al. Double-dose versus standard-dose clopidogrel and high- dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes ( CURRENT-OASIS 7 ): a randomised factorial trial[ J]. Lancet,2010,376 : 1233.
9Ho P M, Maddox T M, Wang L, et al. Risk of adverse outcomes associated with concomitant use of clopidogrel and proton pump inhibitors following acute coronary syndrome[ J ]. JAMA ,2009,301:937.
